Erstad BL. Dosing of medications in morbidly obese patients in the intensive care unit setting.
Intensive Care Med 2004;
30:18-32. [PMID:
14625670 DOI:
10.1007/s00134-003-2059-6]
[Citation(s) in RCA: 114] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/02/2003] [Indexed: 11/26/2022]
Abstract
OBJECTIVE
To derive recommendations for the dosing of commonly used medications in the morbidly obese patient in the ICU.
DATA SOURCES
Articles were obtained through computerized searches involving MEDLINE. The bibliographies of retrieved publications and textbooks were reviewed for additional references.
STUDY SELECTION
All studies involving the pharmacokinetics or pharmacodynamics of medications in obese subjects or patients.
DATA EXTRACTION
The emphasis was on studies involving morbidly obese patients but, in the absence of such data, investigations involving lesser forms of obesity were extracted.
DATA SYNTHESIS
There is a paucity of data upon which to make recommendations for dosing commonly used medications in the morbidly obese patient in the ICU, although recommendations were provided based on the available information.
CONCLUSIONS
There is clearly a need for more investigations involving dosing regimens of medications in the morbidly obese population. Until such studies are available, the clinician must try to derive the best dosing regimens for medications based on the limited pharmacokinetic data available for some agents and clinical judgement.
Collapse